- Country: Serbia
- Summary: Medications Outside the List of Drugs
- RST Ref No: 119086765
- Deadline: 29 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: A257/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Apomorphine hydrochloride, apomorphine hydrochloride hemihydrate \ t, asciminib \ t, avelumab \ t, baclofen in intrathecial pump, which proves a certified SMPC translation to the Serbian language in which this stability data is listed) \ t, balancedCombination of 9 trace traces 20x10ml amp (copper, selenium, manganese, chromium, zinc, iron), Baloxavir Marboksil \ t, Benralizumab \ t, Dexametzam \ t, Durvalumab \ t, Ekulizumab \ t, Etelkalcetid \ t, evolokumab \ t , Faricimab \ t, fremnezumab \ t, fruquintinib \ t, fruquintinib \ t, GancicLovir \ t, givosiran \ t, human normal IG for IV. In need that contains 76% IgG, 12% IGM and 12% IGA \ t
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedications Outside the List of Drugs - Serbia Tender
The UNIVERSITY CLINICAL CENTER OF SERBIA, a Government sector organization in Serbia, has announced a new tender for Medications Outside the List of Drugs. This tender is published on SerbiaTenders under RST Ref No: 119086765 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-29.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
